Last reviewed · How we verify
NCT03830970
Effect of Canned Beans of Multiple Varieties in Daily Amounts of 1 Cup and 1/2 Cup on Serum LDL Cholesterol and Other Cardiovascular Disease Risk Biomarkers in Adults With Elevated LDL Cholesterol
NA trial testing Canned beans of multiple varieties in Hypercholesterolemia in 73 participants. Completed in 5 January 2021.
5 January 2021
Quick facts
| Lead sponsor | University of Guelph |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 73 |
| Start date | 5 March 2019 |
| Primary completion | 5 January 2021 |
| Estimated completion | 5 January 2021 |
| Sites | 2 locations across Canada |
Drugs / interventions tested
- Canned beans of multiple varieties
- White Rice
Conditions studied
- Hypercholesterolemia — all drugs for Hypercholesterolemia →
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Sponsor
University of Guelph
Who can join
18 and older, any sex, with Hypercholesterolemia or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Bean Study will examine the effects of consuming two daily amounts of canned beans of multiple varieties on fasting serum cholesterol profile in adults with elevated LDL cholesterol.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Canned Beans Decrease Serum Total and LDL Cholesterol in Adults with Elevated LDL Cholesterol in a 4-wk Multicenter, Randomized, Crossover Study.
Doma KM, Dolinar KF, Dan Ramdath D, Wolever TMS, et al · · 2021 · cited 10× · PMID 34642756 · DOI 10.1093/jn/nxab323
Verify or expand the search:
- PubMed search for NCT03830970
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypercholesterolemia
Currently open trials in the same condition.
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07374861 — Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Bempedoic Acid in Italy · recruiting
- NCT07295327 — Effect of Two Food Supplements on Lipid Profile in Patients With Mild Hypercholesterolemia · NA · recruiting
- NCT06568601 — Pharmacogenomic Informed Statin Prescribing · NA · recruiting
- NCT06423365 — A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication. · NA · active not recruiting
Other University of Guelph trials
Trials by the same sponsor.
- NCT06186050 — Effects of a High-fat Meal on Exercise-mediated Sympatholysis · NA · completed
- NCT05820256 — The Effects of Milk Protein Versus Soy Protein on Essential Omega-3 Fatty Acid Metabolism · NA · active not recruiting
- NCT05958784 — PKU Carriers Trial (Pilot Study): Impact on Cognition, Mental Health, Blood Pressure and Metabolism · NA · completed
- NCT05942664 — Sleeping Habits on Performance Following Sleep Deprivation · NA · completed
- NCT05514808 — An Intervention to Improve Knowledge on Dietary Supplements Among Varsity Athletes · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03830970 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Guelph
- Last refreshed: 5 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03830970.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing